Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOFLOXACIN Cause Bronchopulmonary aspergillosis? 80 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Bronchopulmonary aspergillosis have been filed in association with LEVOFLOXACIN (Levofloxacin). This represents 0.2% of all adverse event reports for LEVOFLOXACIN.

80
Reports of Bronchopulmonary aspergillosis with LEVOFLOXACIN
0.2%
of all LEVOFLOXACIN reports
9
Deaths
62
Hospitalizations

How Dangerous Is Bronchopulmonary aspergillosis From LEVOFLOXACIN?

Of the 80 reports, 9 (11.3%) resulted in death, 62 (77.5%) required hospitalization, and 12 (15.0%) were considered life-threatening.

Is Bronchopulmonary aspergillosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOFLOXACIN. However, 80 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOFLOXACIN Cause?

Drug hypersensitivity (3,660) Neuropathy peripheral (2,619) Arthralgia (2,594) Pain in extremity (2,317) Pain (2,266) Drug ineffective (2,181) Dyspnoea (2,074) Tendonitis (1,813) Aortic aneurysm (1,767) Nausea (1,694)

What Other Drugs Cause Bronchopulmonary aspergillosis?

TACROLIMUS (968) PREDNISONE (967) DEXAMETHASONE (854) CYCLOPHOSPHAMIDE (824) METHYLPREDNISOLONE (794) PREDNISOLONE (704) MYCOPHENOLATE MOFETIL (702) RITUXIMAB (606) CYCLOSPORINE (583) METHOTREXATE (553)

Which LEVOFLOXACIN Alternatives Have Lower Bronchopulmonary aspergillosis Risk?

LEVOFLOXACIN vs LEVOKETOCONAZOLE LEVOFLOXACIN vs LEVOLEUCOVORIN LEVOFLOXACIN vs LEVOMEPROMAZINE LEVOFLOXACIN vs LEVOMETHADONE LEVOFLOXACIN vs LEVOMILNACIPRAN

Related Pages

LEVOFLOXACIN Full Profile All Bronchopulmonary aspergillosis Reports All Drugs Causing Bronchopulmonary aspergillosis LEVOFLOXACIN Demographics